Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects.
Mason W FreemanMary BondBrian MurphyJames HuiJonathan IsaacsohnPublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)
ClinicalTrials.gov identifier no. NCT05526690.